shire map
Select a
Location

Shire Global

How We Operate

Partnerships

A CLEAR AND FOCUSED BUSINESS DEVELOPMENT STRATEGY

We are constantly seeking out new innovation opportunities through strategic partnerships, acquisitions and licenses. We strive to bolster our core therapeutic areas and expand into high-value adjacent therapeutic areas to create the most value for our patients, partners and Shire.

We are and will continue to strive to be the partner of choice for companies seeking to develop and commercialize innovative therapies for rare diseases.

Within the rare disease space, we have identified eight focus areas where we have existing or developing domain expertise.

 RDFocus-Area-V2

*In these areas, we are also interested in non-orphan later stage opportunities (i.e., post proof of concept).

WHY PARTNER WITH SHIRE?

Our robust pipeline combined with our patient-centric, entrepreneurial culture and collaborative approach will be the engine of future innovation and development of the next generation of therapies. We have a history of successful collaborations and highly flexible deal structures with our partners. We remain committed to finding opportunities that can take our scientific savvy in small molecules and biologics and innovative work in rare diseases, neuroscience, gastrointestinal, hematology, immunology, oncology and ophthalmology to the next level. We are also interested in existing and emerging therapeutic technologies (e.g., small molecules, recombinant proteins, antibodies, gene therapies, gene editing). Shire’s global infrastructure makes us an agile partner, entrepreneurial in spirit and expert at collaboration. Through it all, we remain patient-focused, and absolutely committed to forging meaningful relationships with patient advocates and policy makers.

EXPLORE A PARTNERSHIP WITH SHIRE

To learn more about building a partnership with Shire, please contact us.

 

Mergers & Acquisitions

 BaxaltaDyax
 jeriniNew River Pharma
 NPS PharmaTKT
 ViroPharma

 

Strategic Investments

 Blue Bird BioDBV Technologies
 Inception SciencesUltragenyx


Licensing / Product Focused Acquisition

 Bikam PharmaceuticalsFerroKin BioSciences
 Fibrotech TherapeuticsLotus Tissue Repair
 Lumena PharmaceuticalsMeritage Pharma Inc
 PremacureSarcode Biosciences

Research Collaborations

 ArgenXArmagen
 Boston Childrens HospitalCystic Fibrosis Foundation
 Sanga MDTelethon Institute of Genetics and Medicine

Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE